Cervical intraepithelial neoplasia grade 3 associated with adverse pregnancy outcomes | 2 Minute Medicine
Cervical cancer in pregnancy: diagnosis, staging and treatment - Howe - 2022 - The Obstetrician & Gynaecologist - Wiley Online Library
Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone-length and preterm delivery: a register-based study from western Sweden | BMC Medicine | Full Text
Cancer in Pregnancy | Oncohema Key
Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis | Scientific Reports
Update on ASCCP Consensus Guidelines for Abnormal Cervical Screening Tests and Cervical Histology | AAFP
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Case Presentations: Pre-Invasive Cervical Neoplasia - ppt video online download
Frontiers | Evaluation of Cervical Intraepithelial Neoplasia Occurrence Following the Recorded Onset of Persistent High-Risk Human Papillomavirus Infection: A Retrospective Study on Infection Duration
Gynecologic cancer in pregnancy - Gynecologic Oncology
Adverse Pregnancy Outcomes Reported for Women Diagnosed With CIN 3 - Consumer Health News | HealthDay
Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2—a prospective clinical multicenter cohort study - American Journal of Obstetrics & Gynecology
Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience - European Journal of Obstetrics and Gynecology and Reproductive Biology
Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months - European Journal of Obstetrics and Gynecology and Reproductive Biology
PDF] Cervical cancer screening in pregnancy. | Semantic Scholar
Gebelikte Rahim Ağzı Kanseri ve Rahim Ağzı Kanseri Öncüllerinin (CIN I – II –III, Servikal Displaziler) Yönetimi